Role of Peptidyl arginine deiminase 4-dependent macrophage extracellular traps formation on Type 1 Diabetes pathogenesis.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
13 Aug 2024
Historique:
received: 24 07 2024
accepted: 06 08 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 13 8 2024
Statut: aheadofprint

Résumé

Excessive macrophage extracellular traps (METs) formation has been implicated in several autoimmune disease pathogenesis; however, its impact on Type 1 Diabetes (T1D) and related mechanisms remains enigmatic. Here, we demonstrated the pivotal role of peptidyl arginine deiminase 4 (PAD4) in driving profuse METs formation and macrophage M1 polarization in intestinal inflammation of non-obese diabetic (NOD) mice. Genetic knockout of PAD4 or adoptive transfer of METs alters the proportion of pro-inflammatory T cells in the intestine, subsequently influencing their migration to the pancreas. Combining RNA sequencing and CUT&Tag analysis we found activated PAD4 transcriptionally regulated CXCL10 expression. This study comprehensively investigated how excessive PAD4-mediated METs formation in the colon increases the aggravation of intestinal inflammation and pro-inflammatory T cells migration, and finally involves T1D progression, suggesting that inhibition METs formation may be a potential therapeutic target for T1D.

Identifiants

pubmed: 39137121
pii: 157085
doi: 10.2337/db23-1000
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the American Diabetes Association.

Auteurs

Yiming Shen (Y)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Ruiya Shi (R)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

ShiPing Lu (S)

Center for Translational Research in Infection and Inflammation, Tulane University, New Orleans, United States.

Yan Wang (Y)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Ziqi Zhou (Z)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Chenhua Wu (C)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Qi You (Q)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Hongye Fan (H)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Jie Wu (J)

School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Classifications MeSH